Skip to main content

Onconetix, Inc.

ONCO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001782107

No open-market purchases or sales by Onconetix, Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $73.9K in total; no superinvestor holds it.

13F holders, Q4 2022

Institutional positions in Onconetix, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
18
−1 vs. Q3 2022
Shares held
1.94M
−421.6K (−17.9%) vs. Q3 2022
Total value
$2.13M
−$1.90M (−47.2%) vs. Q3 2022
New holders
6
6 more added
Sold out
7
4 more reduced

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ONCO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 18 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 13 institutionsQ2 2022: 10 institutionsQ3 2022: 19 institutionsQ4 2022: 18 institutionsQ1 2023: 13 institutionsQ2 2023: 20 institutionsQ3 2023: 19 institutionsQ4 2023: 22 institutionsQ1 2024: 17 institutionsQ2 2024: 20 institutionsQ3 2024: 8 institutionsQ4 2024: 11 institutionsQ1 2025: 13 institutionsQ2 2025: 7 institutionsQ3 2025: 8 institutionsQ4 2025: 7 institutionsQ1 2026: 5 institutionsQ2 2026: 6 institutions
Value heldQ4 2022: $2.13M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $25.9MQ2 2022: $2.37MQ3 2022: $4.03MQ4 2022: $2.13MQ1 2023: $1.73MQ2 2023: $2.70MQ3 2023: $1.82MQ4 2023: $478.6KQ1 2024: $367.8KQ2 2024: $491.6KQ3 2024: $3.23MQ4 2024: $241.7KQ1 2025: $26.7KQ2 2025: $43.0KQ3 2025: $303.7KQ4 2025: $95.3KQ1 2026: $24.9KQ2 2026: $73.9K
Institutions holding ONCO and their total value by quarter
QuarterHoldersValue
Q2 20266$73.9K
Q1 20265$24.9K
Q4 20257$95.3K
Q3 20258$303.7K
Q2 20257$43.0K
Q1 202513$26.7K
Q4 202411$241.7K
Q3 20248$3.23M
Q2 202420$491.6K
Q1 202417$367.8K
Q4 202322$478.6K
Q3 202319$1.82M
Q2 202320$2.70M
Q1 202313$1.73M
Q4 202218$2.13M
Q3 202219$4.03M
Q2 202210$2.37M
Q1 202213$25.9M
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Onconetix, Inc.; share changes are against Q3 2022.

Institutions holding ONCO in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
American Financial Group Inc940,762$1.03M0.35%+483,851+105.9%Added
Sabby Management, LLC564,046$620.5K1.66%+11,797+2.1%Added
Cetera Advisor Networks LLC132,800$146.1K0.00%00.0%Unchanged
BlackRock Inc.61,824$68.0K0.00%+200+0.3%Added
Vanguard Group Inc45,090$49.6K0.00%00.0%Unchanged
Fifth Third Bancorp33,675$37.0K0.00%+20,205+150.0%Added
Bank of New York Mellon Corp27,278$30.0K0.00%+27,278New
Renaissance Technologies LLC22,548$25.0K0.00%−65,162−74.3%Reduced
Two Sigma Advisers, LP19,400$21.3K0.00%−3,000−13.4%Reduced
Millennium Management LLC18,051$20.0K0.00%−21,149−54.0%Reduced
Two Sigma Investments, LP17,813$19.6K0.00%−16,576−48.2%Reduced
Virtu Financial LLC16,340$18.0K0.00%+16,340New
Bahl & Gaynor Inc12,150$13.4K0.00%+12,150New
Geode Capital Management, LLC11,610$12.0K0.00%+11,610New
Tower Research Capital LLC (TRC)10,096$11.0K0.00%+9,777+3,064.9%Added
UBS Group AG2,633$2.90K0.00%+2,633New
Wells Fargo & Company33$360.00%+17+106.3%Added
Bank of America Corp10$110.00%+10New
Armistice Capital, LLC0$00.00%−858,360−100.0%Sold out
Jane Street Group, LLC0$00.00%−21,769−100.0%Sold out
Squarepoint Ops LLC0$00.00%−17,003−100.0%Sold out
Citadel Advisors LLC0$00.00%−14,274−100.0%Sold out
FMR LLC0$00.00%−43−100.0%Sold out
Royal Bank of Canada0$00.00%−54−100.0%Sold out
O'Dell Group, LLC0$00.00%−115−100.0%Sold out